Cover Image
市場調查報告書

全球避孕產品市場

Global Contraceptives Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 306896
出版日期 內容資訊 英文 109 Pages
訂單完成後即時交付
價格
Back to Top
全球避孕產品市場 Global Contraceptives Market 2014-2018
出版日期: 2014年06月20日 內容資訊: 英文 109 Pages
簡介

全球避孕產品市場,預計從2013年到2018年,以5.90%的年複合成長率(CAGR)擴大。

本報告提供全球避孕產品市場現狀及其成長預測、產品(避孕藥、設備)趨勢、市場成長因素與課題、主要供應商的資訊等。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各產品的市場區隔

  • 藥物
  • 設備
  • 避孕產品比較

第8章 全球避孕藥市場

  • 避孕藥市場的規模與預測
  • 口服避孕藥丸
  • 注射避孕藥
  • 局部避孕藥

第9章 全球避孕設備市場

  • 避孕設備的市場規模與預測
  • 保險套
  • 子宮內避孕器(IUD)

第10章 地理區分

第11章 購買標準

第12章 市場成長因素

第13章 成長因素與其影響

第14章 市場課題

第15章 成長因素與課題的影響

第16章 市場趨勢

第17章 趨勢與其影響

第18章 業者情勢

第19章 業者情勢

  • 競爭模式
    • 主要消息
    • M&A
  • 市場佔有率分析
  • 其他卓越供應商

第20章 主要供應商分析

第21章 相關報告

目錄
Product Code: IRTNTR3648

About Contraceptives

Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods include male sterilization (vasectomy), and female sterilization including tubal occlusion or hysteroscopic sterilisation. Temporary methods can be hormonal and non-hormonal. The non-hormonal methods include condoms, diaphragms, sponges, withdrawal methods, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. Hormonal methods contain synthetic sex hormones estrogen/progestin or a combination of both which prevent ovulation and thicken cervical mucus in the female. Currently, hormonal methods can only be used by women. The development of a male hormonal contraceptive is an active research area.

TechNavio's analysts forecast the Global Contraceptives market will grow at a CAGR of 5.90 percent over the period 2013-2018.

Covered in this Report

The Global Contraceptives market can be segmented broadly into two divisions: Drugs and Devices. This report covers the present scenario and the growth prospects of the Global Contraceptives market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for contraception which include:

Drugs (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives)

Devices (Male & Female condoms, Diaphragms, IUDs, Vaginal Rings, Female Sponges and Subdermal Contraceptive Implants)

TechNavio's report, the Global Contraceptives Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Contraceptives market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Actavis plc
  • Bayer AG
  • Johnson & Johnson's Janssen Pharmaceuticals, Inc.
  • Merck & Co.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries, Ltd

Other Prominent Vendors

  • Adamis Pharmaceuticals
  • Corp.
  • Agile Therapeutics, Inc.
  • ANI Pharmaceuticals, Inc.
  • Ansell Ltd.
  • Apothecus Pharmaceutical Corp.
  • Blairex Laboratories Inc.
  • Church & Dwight, Co. Inc.
  • Caldwell Consumer Health, LLC.
  • Ferring International Center S.A
  • Fuji Latex Co., Ltd.
  • HLL Lifecare Limited
  • Mayer Laboratories
  • Medicines 360
  • Karex Berhad
  • Lipocine Inc.
  • Lupin Pharmaceuticals, Inc.
  • Mylan Laboratories Inc.
  • Okamoto Industries, Inc.
  • Pantarhei Bioscience B.V.
  • Paul Hartmann AG
  • Reckitt Benckiser Group Plc
  • The Female Health Company

Key Market Driver

  • Growing Prevalence of Unwanted Pregnancies.

For a full, detailed list, view our report.

Key Market Challenge

  • Growing Prevalence of Unwanted Pregnancies.
  • Introduction of Cheap Generic Contraceptives

For a full, detailed list, view our report.

Key Market Trend

  • Increasing Strategic Partnerships.

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Products Type

  • 07.1.1. Drugs
  • 07.1.2. Devices
  • 07.1.3. Comparison of Different Types of Contraceptives

08. Global Contraceptives Drugs Market

  • 08.1. Market Size and Forecast of Contraceptives Drugs
  • 08.2. Global Oral Contraceptives Pills Market
    • 08.2.1. Market Size and Forecast of Oral Contraceptives Pills
  • 08.3. Global Injectable Contraceptives Market
    • 08.3.1. Market Size and Forecast of Injectable Contraceptives
  • 08.4. Global Topical Contraceptives Market
    • 08.4.1. Market Size and Forecast of Topical Contraceptives

09. Global Contraceptives Devices Market

  • 09.1. Market Size and Forecast of Contraceptives Devices
  • 09.2. Global Condoms Market
    • 09.2.1. Market Size and Forecast of Condoms
  • 09.3. Global IUDs Market
    • 09.3.1. Market Size and Forecast of IUDs

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Share Analysis 2013
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

21. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Contraceptives Market 2013-2018 (US$ billion)
  • Exhibit 3: Global Contraceptives Market Segmentation by Product Type
  • Exhibit 4: Global Contraceptives Market by Product Type 2013
  • Exhibit 5: Global Contraceptives Market Segmentation by Product Type
  • Exhibit 6: Global Contraceptives Drugs Market Segmentation
  • Exhibit 7: Global Contraceptives Drugs Market 2013-2018 (US$ billion)
  • Exhibit 8: Global Oral Contraceptives Pills Market 2013-2018 (US$ billion)
  • Exhibit 9: Global Injectable Contraceptives Market 2013-2018 (US$ billion)
  • Exhibit 10: Global Topical Contraceptives Market 2013-2018 (US$ billion)
  • Exhibit 11: Global Contraceptives Drugs Market 2013-2018 (US$ billion)
  • Exhibit 12: Global Contraceptives Drugs Market 2013-2018 (Revenue in Percentage)
  • Exhibit 13: Global Contraceptives Devices Market Segmentation
  • Exhibit 14: Global Contraceptives Devices Market 2013-2018 (US$ billion)
  • Exhibit 15: Global Condoms Market 2013-2018 (US$ billion)
  • Exhibit 16: Global Contraceptives Market by Geographical Segmentation (Revenue in Percentage)
  • Exhibit 17: Snapshot of Global Contraceptives Market Pipeline 2013
  • Exhibit 18: Licensing Agreements in Global Contraceptives Market (in Percentage)
Back to Top